Revised by Kevin L. Zacharoff, MD December 2015 There are many different types of pain medications available to help healthcare providers treat patients with chronic pain. Depending on the specific medication, they can be obtained by prescription or are available over-the-counter (OTC). Pain medications provide an important component of most treatment plans intended to relieve… Read more »
Tag: Kevin Zacharoff
An interview with Kevin L. Zacharoff, MD, a licensed, board-certified anesthesiologist, about the PAINWeek 2015 conference.
Empirical is typically defined1 as “originating in or based on observation or experience” (e.g., empirical data), “relying on experience or observation alone often without due regard for system and theory” (e.g., an empirical basis for a theory), or “capable of being verified or disproved by observation or experiment” (e.g., empirical laws). It is quite common for… Read more »
An interview with Kevin L. Zacharoff, MD and licensed, board-certified anesthesiologist about the PAINWeek 2014 conference.
An interview with Kevin L. Zacharoff, MD about standardizing the assessment of patients with chronic pain; a PainEDU June webinar recap.
One of the four definitions that the Merriam-Webster dictionary offers for tampering is “to render something harmful or dangerous by altering its structure or composition.” There is nothing in the definition about intention, such as intent to break the law, intent “to get high,” or other aberrant drug-related behaviors; just the fact that something that changes structure… Read more »
An interview with Kevin L. Zacharoff, MD and licensed, board-certified anesthesiologist about ER/LA opioid REMS and REMS education.
Census data shows that the average number of people in the United States turning 65 each day is approximately 10,000. More people will turn 65 every day for the next 20 years, making this one of the fastest growing segments of the U.S. population. It is reasonable to think that the number of people seeking medical attention for pain-related… Read more »
At a time of ever-ratcheting concern about the safety of our food and the appropriate, safe use of prescription drugs, the Food and Drug Administration (FDA) has moved forward in the past with a number of initiatives to better protect public health. Among them are efforts that are likely to impact how pharmaceutical companies help… Read more »
Many clinicians may have reluctance to prescribe opioids for patients in pain outside of the most controlled of situations (i.e., when the patient is a hospital inpatient). This phenomenon is fairly well accepted by clinicians and patients, and is often the result of some combination of a variety of factors: – Clinicians who are not experts… Read more »